Cellvento^® 4CHO-X COMP

This page describes the financial and operational advantages offered by the Cellicon® Cell Retention Device in an N-1 perfusion process at the 2,000 L scale in comparison to a cell retention device from another supplier.

This page describes the design attributes of the Cellicon^® filter assembly for cell retention and how they simplify scale-up of intensified upstream processes.

Streamline upstream process monitoring with embedded Raman ready-to-use models for easy implementation and improved process understanding

How the Cellicon^® filter and controller enables seamless adoption of a perfused N-1 seed train step into the cell expansion process.

Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.

Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.

Learn more about cell culture media development for mAB development and manufacturing, and the products you need for this step.

This page describes the use of a small-scale perfusion bioreactor with integrated microfluidic flow control and sensor technologies to predict large-scale processes.